Aurora Cannabis Inc. (ACB)
| Previous Close | 5.41 |
| Open | 5.55 |
| Bid | 5.76 x 100 |
| Ask | 5.85 x 100 |
| Day's Range | 5.55 - 5.87 |
| 52 Week Range | 2.84 - 11.50 |
| Volume | |
| Avg. Volume | 1,422,940 |
| Market Cap | 318.28M |
| Beta (5Y Monthly) | 2.72 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.47 |
| Earnings Date | Nov 07, 2024 - Nov 11, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 31.82 |
CNW GroupAurora Cannabis and Vectura Fertin Pharma, Inc. announce launch of novel Luo CBD lozenge
Aurora Cannabis Inc. ("Aurora") (NASDAQ: ACB) (TSX: ACB), a leading Canadian-based global medical cannabis company, and Vectura Fertin Pharma, Inc., an innovator in wellness and healthcare, are pleased to announce the launch of the newly developed Luo CBD lozenge.
CNW GroupAurora Cannabis Announces Results of 2024 Annual General and Special Meeting
Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), a leading Canada-based global medical cannabis company, is pleased to announce the voting results from its Annual General and Special Meeting of Shareholders (the "Meeting") held Friday August 9, 2024 by virtual webcast. The total number of shares represented by shareholders present in person (virtually) and by proxy at the Meeting was 14,855,306, representing 27.23% of Aurora's issued and outstanding common shares as of
Simply Wall St.Aurora Cannabis First Quarter 2025 Earnings: Beats Expectations
Aurora Cannabis ( TSE:ACB ) First Quarter 2025 Results Key Financial Results Revenue: CA$83.4m (up 11% from 1Q 2024...
